Sophos IRB and ALCMI partner to support lung cancer research
Northwest Biotherapeutics and NHSBT collaborate to support production of DCVax-L
Vir Biotechnology's VIR-5500 receives FDA Fast Track designation for prostate cancer
Voyager signs cancer research mission management contract
AstraZeneca completes USD2bn equity investment in Summit Therapeutics
GE HealthCare to acquire SOFIE Biosciences for USD945m
Avimer Bio and CNIO publish JACS study on computational design of self‑assembling protein cages
MHRA approves Zepzelca and atezolizumab as first-line maintenance therapy for ES-SCLC in the UK
AstraZeneca invests USD2bn in Summit Therapeutics to advance ADC and cancer-drug combinations
Fuse Oncology and Associated Medical Professionals of NY launch FuseRx proof of concept
Leo Cancer Care invests in children's experience of radiotherapy, following world-first treatments
Innovent expands global Phase 3 study of IBI363/TAK-928 to include non-squamous NSCLC
FDA approves WELIREG and LENVIMA combination for previously treated advanced renal cell carcinoma
AstraZeneca's IMFINZI combination receives US Priority Review for muscle-invasive bladder cancer